NAGA Antikörper (AA 43-329) (Fluoro488)
Kurzübersicht für NAGA Antikörper (AA 43-329) (Fluoro488) (ABIN8012965)
Target
Alle NAGA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 43-329
-
Verwendungszweck
- Anti-NAGA Antibody Fluoro488 Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Homologie
- Human NAGAshares 86.7%,85.4% amino acid (aa) sequence identity with mouse,rat NAGA,respectively.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human NAGA recombinant protein (Position: D43-R329). Human NAGAshares 86.7% and 85.4% amino acid (aa) sequence identity with mouse and rat NAGA, respectively.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- NAGA (N-Acetylgalactosaminidase, alpha (NAGA))
-
Andere Bezeichnung
- NAGA
-
Hintergrund
-
Background: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
Gene Full Name: alpha-N-acetylgalactosaminidase
-
Gen-ID
- 4668
-
UniProt
- P17050
Target
-